FDA approves 'glowing tumor' imaging drug to better identify ovarian cancer cells
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons ...
Nov 30, 2021
0
3